Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EXPAND-EV

Financiado

Cerrado

EXPANDing the value of Extracellular Vesicles as carriers of biomarker and thera...

EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healhcare Extracellular vesicles (EVs) have been identified as important signaling mediators in a myriad of physiological and pathological processes. There is an emerging effort to advance the exploitation of EVs in precision healthcare, wi... ver más

31/12/2028

HEMIJSKI FAKULTET...

Presupuesto desconocido

Líder del proyecto

HEMIJSKI FAKULTET UNIVERZITET U BEOGRADU No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2025-01-01

HORIZON-MSCA-2023-SE-01-01: MSCA Staff Exchanges 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 11 meses

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

HEMIJSKI FAKULTET UNIVERZITE...

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PLATAFORMA DE BIOMARCADORES PREDICTIVOS PARA... PLATAFORMA DE BIOMARCADORES PREDICTIVOS PARA EL ESTUDIO PRE... 476K€ Cerrado

EVEREST Extracellular Vesicle Research Exchanges for Advanced Biomar... Cerrado

PHOREVER PHOtonic integrated OCT-enhanced flow cytometry for canceR a... 5M€ Cerrado

NEXUS automated in-line separatioN and dEtection of eXtracellular... 2M€ Cerrado

CATCH Novel T cell therapies against lymphocytic leukaemia 150K€ Cerrado

PLEC2021-007892 Plataforma (Oncodeeplasm) para inmunoensayos optoplasmónicos... 336K€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2025-01-01
Fecha Fin: 2028-12-31

Líder del proyecto

HEMIJSKI FAKULTET UNIVERZITET U BEOGRADU No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Extracellular vesicles (EVs) have been identified as important signaling mediators in a myriad of physiological and pathological processes. There is an emerging effort to advance the exploitation of EVs in precision healthcare, with special emphasis on drug delivery and liquid biopsy. However, the current technology readiness level in the field and lack of standardized methodology guidelines are limiting the exploitation of EVs, so a significant leap toward the establishment of novel tools has to be made. EXPAND-EV’s main goal is to provide a unique solution for advancing the current diagnostic and therapeutic potential of EVs by developing and implementing versatile, scalable, cost-effective and reproducible purification systems, based on single-domain antibody affinity technology for high-performance scalable EVs capture, in two parallel lines of research: (I)the system will be validated in clinical laboratory settings on breast (BC), liver (HC) and lung cancer (LC) by analyzing differential expression of multi -omics (proteomic, glycomic and transcriptomic) EVs-related features, with the goal to develop a panel of biomarkers that would contribute in timely diagnostics, enable a convenient and non-invasive prognosis assessment and tailored therapy. (II)development of GMP-compliant protocol for producing edible plant EVs as carriers of therapeutic siRNA molecules. Their safety profile and therapeutic potential will be tested on BC, HC and LC cell lines and mouse models. By establishing a consortium composed of excellent research groups and SMEs across Europe, EXPAND-EV will bring forth the needed paradigm shift in EVs research by solving the major bottleneck issue in the field. Creating a simple, robust, cheap, scalable and reproducible EVs purification system will provide much-needed technology for application of EVs in personalized medicine, leading the transition of EVs use from a promising laboratory concept to a feasible and applicable theranostic agent.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores